Antitumor activity of a novel survivin siRNA

Yuhuan Li, Yuhuan Li, Robert J. Lee, Xi Wang, Lin Du, Lingzhi Zhao, Yan Liu, Lesheng Teng

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Abstract

Breast cancer resistance to therapy can result from expression of antiapoptotic genes. Survivin is an antiapoptotic gene that is over expressed in most human tumors. RNA interference using short interfering RNA (siRNA) can be used to specifically inhibit survivin expression. A novel siRNA targeting survivin was used to process MCF-7 cells. Cellular survivin mRNA and protein levels were determined by real-time qRT-PCR and Western blot, respectively. Cellular morphology and cell cycle were determined by fluorescence microscopy and flow cytometry. Cell proliferation was measured by MTT assay. Our data showed that the novel survivin-targeted siRNA could efficiently knockdown the expression of survivin, inhibit cell proliferation and cell cycle, especially at the G2/M checkpoint. These data suggest that the siRNA has potential for therapeutic applications.

Original languageEnglish
Pages (from-to)1887-1890
Number of pages4
JournalPakistan Journal of Pharmaceutical Sciences
Volume28
Issue number5 Supplementary
Publication statusPublished - 1 Sept 2015
Externally publishedYes

Cite this